Maria-Luisa Maccecchini - 06 Dec 2021 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Maria L. Maccecchini
Issuer symbol
ANVS
Transactions as of
06 Dec 2021
Net transactions value
$0
Form type
4
Filing time
08 Dec 2021, 16:00:47 UTC
Previous filing
13 Oct 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +112,995 $0.000000 112,995 06 Dec 2021 Common Stock 112,995 $20.97 Direct F1
transaction ANVS Stock Option (right to buy) Award $0 +145,305 $0.000000 145,305 06 Dec 2021 Common Stock 145,305 $20.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is 100% vested.
F2 The stock option shall vest in two installments: (i) the first installment of 72,653 shares on March 31, 2022 and (ii) a second and final installment of 72,652 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.